These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27456934)

  • 1. The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials.
    Huang H; Chen G; Liao D; Zhu Y; Pu R; Xue X
    Obes Rev; 2016 Dec; 17(12):1329-1340. PubMed ID: 27456934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A; Serban C; Ursoniu S; Wong ND; Muntner P; Graham IM; Mikhailidis DP; Rizzo M; Rysz J; Sperling LS; Lip GY; Banach M;
    Int J Cardiol; 2015; 189():47-55. PubMed ID: 25885871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-fat compared with high-fat diet on cardiometabolic indicators in people with overweight and obesity without overt metabolic disturbance: a systematic review and meta-analysis of randomised controlled trials.
    Lu M; Wan Y; Yang B; Huggins CE; Li D
    Br J Nutr; 2018 Jan; 119(1):96-108. PubMed ID: 29212558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial.
    van der Made SM; Plat J; Mensink RP
    PLoS One; 2015; 10(3):e0118393. PubMed ID: 25790328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.
    Liu Y; Ma W; Zhang P; He S; Huang D
    Clin Nutr; 2015 Feb; 34(1):27-34. PubMed ID: 24731650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Resveratrol Supplementation in Overweight and Obese Humans: A Systematic Review of Randomized Trials.
    Christenson J; Whitby SJ; Mellor D; Thomas J; McKune A; Roach PD; Naumovski N
    Metab Syndr Relat Disord; 2016 Sep; 14(7):323-33. PubMed ID: 27379440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.
    Wong RH; Howe PR; Buckley JD; Coates AM; Kunz I; Berry NM
    Nutr Metab Cardiovasc Dis; 2011 Nov; 21(11):851-6. PubMed ID: 20674311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol.
    Wicklow B; Wittmeier K; T' Jong GW; McGavock J; Robert M; Duhamel T; Dolinsky VW
    Biochem Cell Biol; 2015 Oct; 93(5):522-30. PubMed ID: 26305052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of l-carnitine supplementation for weight management in overweight and obese adults: An updated systematic review and dose-response meta-analysis of randomized controlled trials.
    Askarpour M; Hadi A; Miraghajani M; Symonds ME; Sheikhi A; Ghaedi E
    Pharmacol Res; 2020 Jan; 151():104554. PubMed ID: 31743774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis.
    Zhang L; Liu Z; Liao S; He H; Zhang M
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1611-1621. PubMed ID: 34043049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A
    Nutr Rev; 2013 Dec; 71(12):822-35. PubMed ID: 24111838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors.
    Nordmann AJ; Suter-Zimmermann K; Bucher HC; Shai I; Tuttle KR; Estruch R; Briel M
    Am J Med; 2011 Sep; 124(9):841-51.e2. PubMed ID: 21854893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of flavonoids-containing supplements on insulin resistance and associated metabolic risk factors in overweight and obese subjects: a systematic review and meta-analysis of 25 randomized controlled trials.
    Yao J; Zhang Y; Zhao J; Wang XZ; Lin YP; Sun L; Lu QY; Fan GJ
    Front Endocrinol (Lausanne); 2022; 13():917692. PubMed ID: 35937836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture and related techniques for obesity and cardiovascular risk factors: a systematic review and meta-regression analysis.
    Chen J; Chen D; Ren Q; Zhu W; Xu S; Lu L; Chen X; Yan D; Nie H; Zhou X
    Acupunct Med; 2020 Aug; 38(4):227-234. PubMed ID: 32310001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials.
    Fogacci F; Tocci G; Presta V; Fratter A; Borghi C; Cicero AFG
    Crit Rev Food Sci Nutr; 2019; 59(10):1605-1618. PubMed ID: 29359958
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.
    Dash S; Xiao C; Morgantini C; Szeto L; Lewis GF
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2895-901. PubMed ID: 24072699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Prebiotic Products on Decreasing Adiposity Parameters in Overweight and Obese Individuals: A Systematic Review and Meta- Analysis.
    Qu H; Song L; Zhang Y; Gao ZY; Shi DZ
    Curr Med Chem; 2021; 28(2):419-431. PubMed ID: 31886746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial on the effects of 2010 Dietary Guidelines for Americans and Korean diet patterns on cardiovascular risk factors in overweight and obese adults.
    Schroeder N; Park YH; Kang MS; Kim Y; Ha GK; Kim HR; Yates AA; Caballero B
    J Acad Nutr Diet; 2015 Jul; 115(7):1083-92. PubMed ID: 26115560
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.